Hearing impairment is the most common sensory defect, affecting millions of people ranging from newborns to the elderly. Causes of hearing impairment are often associated with damage to one or both types of hair cells (Figure ): inner hair cells (IHCs) and/or outer hair cells (OHCs). Both mechanoreceptor cell populations are housed in the mammalian organ of Corti (OC), a cellular matrix within the cochlea (Figure ). Each hair cell has a staircase array of stereocilia (actin-filled villi) located at the apical surface of the cell body. Several different kinds of extracellular links connect individual stereocilia into a bundle, allowing the structure to move as a unit in response to mechanical stimulation [
1-
5]. A tip link connects the top of each shorter stereocilium to the side of its taller neighbor [
6]. Vibrations of the basilar membrane result in deflection of the hair bundles, which modulate tension on the tip links, thereby controlling the open probability of cation-selective mechanoelectrical transduction (MET) channels [
6,
7]. Cations, principally K
+ and Ca
++, flow through MET channels and ultimately change the membrane potential. In IHCs the membrane potential facilitates afferent neurotransmitter release. Hence, these cells are considered the true sensory receptors for hearing (for review, see [
8]). In contrast, OHCs undergo rapid somatic length changes when the voltage across their basolateral membranes is altered [
9-
12]. This somatic electromotility is thought to function as part of the cochlear amplifier by providing local mechanical enhancement of the basilar membrane's vibratory pattern [
8]. Without OHCs, hearing threshold is elevated by 40–50 dB [
13], frequency resolution deteriorates [
14] and the ear's operation is linearized [
15].
Prestin is the molecule responsible for generating OHC somatic electromotility [
16]. Prestin proteins are abundantly expressed in the OHC basolateral membrane [
17] and are known to underlie somatic electromotility [
16]. Prestin knockout (KO) mice show a loss of OHC electromotility, an increase in hearing threshold of ~50 dB, and a loss of frequency selectivity. In the prestin-KO model, OHCs are shorter than normal, and progressive OHC death is observed [
18,
19]. In order to eliminate potential deleterious effects due to the anatomical changes, two prestin knock-in (KI) mouse models have been created: C1 KI and 499 KI. C1-KI mice carry an altered but fully functional prestin: C1-mutant [
20]. C1-KI mice have normal cochlear amplification and show no OHC loss [
21]. In contrast, 499-KI mice carry a V409H/Y501H mutation in which prestin loses almost all motile function but retains its ability to target the plasma membrane (PM) [
22]. Even so, progressive OHC death is still found in the 499-KI mice [
23]. To restate: OHCs that lack prestin, as well as OHCs that lack fully
functional prestin, show significant cell death due to some unknown mechanism. Although the functions of prestin-associated proteins may provide insights into OHC death, little is known regarding interactions between prestin and other proteins.
In order for the OHC's motor action to affect peripheral auditory function, a normal transduction of mechanical into electrical signals by the MET apparatus located at the tips of the stereocilia is required. Similar to other sensory systems [
24], this MET apparatus is a complex composed of several proteins organized in an elegant and sophisticated fashion [
25]. Mutations of these proteins cause damage to stereocilia and result in deafness (for review see [
26]). By using various experimental methods and different species ranging from zebrafish to human, many components likely to be associated with the MET apparatus have been identified, including cdh23, myosin1c, protocadherin 15 (PCDH15) and harmonin (for review see [
27]). However, additional important elements, including the MET channel protein itself, remain unknown. It is also known that the MET apparatus gives rise to active hair-bundle motility, indicating that it is capable of exerting forces to amplify mechanical stimuli [
28-
31]. This force was suggested to arise from myosin1c motors involved in slow adaptation and from the Ca
++-dependent reclosure of MET channels (fast adaptation) (for review, see [
27,
32,
33]. However, in spite of several proposed models [
33], the mechanism for fast adaptation is not fully understood. In order to understand the association between fast adaptation and amplification, it is essential to know where Ca
++ action occurs. Several Ca
++-dependent mechanisms for fast adaptation have been proposed (for review, see [
27,
33]). For example, Ca
++ could bind directly to the transduction channel [
34,
35]. Alternatively, Ca
++ could bind to an intracellular elastic "reclosure element" or "release element" in series with the channel, although the nature of these elements is not known [
36-
38].
Recent evidence suggests that the tip link is composed of cdh23 and PCDH15 [
39-
42], which are both members of a membrane adhesion glycoprotein family with cytoplasmic domains containing no significant homology to any other known proteins [
43,
44]. Although some data indicate that cdh23 is a developmental protein that disappears shortly after the onset of hearing [
45], mutations in cdh23 disrupt hair-bundle organization and give rise to deafness and vestibular dysfunction in waltzer mice [
43].
Cdh23 is also a gene associated with age-related hearing loss [
43]. Similar to mice, different mutations in the human
cdh23 gene can cause DFNB12 and Usher syndrome 1D [
46,
47]. Hence, the tip link is indispensable for hearing function [
48]. Although tip link-associated proteins will be important components of the MET apparatus, hair cells make up a small percentage of the cell population in the cochlea [
49], implying that many of these components may be expressed at extremely low levels. Therefore, gene products associated with MET-apparatus components could remain undetected when the entire cochlea or the organ of Corti is used as source material for either RNA or protein investigations. Furthermore, many proteins identified via high-throughput systems (either RNA or protein-based) do not have conserved functional domains indicating their function [
50]. These obstacles make searching for MET-components challenging. Lacking knowledge about protein components in the MET apparatus limits our understanding of normal and impaired cochlear physiology.
Several methods have been developed to identify protein-protein interactions. For example, proteomics combines mass spectrometry with co-immunoprecipitation. A major advantage of this approach is the ability to identify physiologically relevant protein-protein interactions that exist within stereocilia
in vivo [
51]. Disadvantages such as low sensitivity and high cost make this approach technically challenging when searching for extremely low-level proteins like MET apparatus components. Alternatively, a genetic approach such as the yeast two-hybrid system, is extremely sensitive and, therefore, suitable for identifying low-abundance protein partners. However, the conventional nucleus-based yeast two-hybrid system requires that protein-protein interactions occur in the nucleus where membrane proteins such as prestin and cdh23 do not reside. In order to overcome these obstacles, we adopted a membrane-based yeast two-hybrid system developed by the Stagljar group [
52], in which the transmembrane region and cytoplasmic tail(s) of targeted proteins were used as bait. This system permits identification of proteins that are in the cytoplasm and/or in the cell membrane. Because the bait contains the entire transmembrane region and cytoplasmic tail(s), it will better preserve the native three-dimensional structure of a given protein than does use of the cytoplasmic tail alone as in the conventional nucleus-based yeast two-hybrid system. For this reason, partners identified using the membrane-based approach are more likely to reflect potential
in vivo interactions. Like other yeast two-hybrid systems, this screen can generate a great number of false positive clones that often bury real signals. Therefore, we built an OHC cDNA library to reduce physiologically irrelevant partners. Using OHC cDNA as source material further increases the sensitivity and decreases false positives. Because cdh23, a component of stereocilia-based cochlear amplification, is located at the apical membrane (tip of hair bundles) [
43], and prestin, the agent of somatic electromotility-based cochlear amplification, is at the basolateral membrane [
17], we expect that they will have different associated proteins. Identifying and understanding the interactions between each of these two proteins and their potential partners contributes to our knowledge of OHC-based cochlear amplification and mechanoelectrical transduction. It also allows for the possible identification of new deafness-related genes, thereby enabling other investigators to manipulate their functions for therapeutic purposes through molecular biological strategies, pharmacological treatments, and/or gene therapies.